Novel Shingles Pain Treatment Lauched In The UK

Grünenthal announced today that it have be granted a UK licence in favour of its modern legible Versatis(R) (5% lidocaine medicated plaster). Versatis be licensed for the use of neuropathic dulled pain associated beside preceding herpes zoster (shingles) debauchery, also distinctive by means of post-herpetic neuralgia (PHN)1.

Versatis grant a topical and non-systemic stance for the treatment of localised neuropathic pain symptom associated with PHN, largely label as incineration, shooting or stabbing. It is an ahead of its time suspension of the regional anaesthetic lidocaine and a silky hydrogel plaster, come together efficacious treatment and guileless handling with a proven tolerability and sanctuary profile1.

The plaster offers nippy and lasting pain relief 30 report after application2. Following a once year by way of day 12 hours-on/12 hours-off candidature agenda, capable of three plasters can be nearly new at one event. It can be used as monotherapy or in combination with patient’s extant analgesia, and clinical trial individual shown no clinically related tablets interactions1.

The launch of Versatis coincide with the announcement of a new opinion survey that plan the impact of PHN against model of energy. Conducted by the Barts Pain Research Group, the survey release that ended 80% of respondents get the impress that PHN have negatively exaggerated their competency to submerge above terrain life, whilst almost 50% felt suicidal or depressed as a influence of PHN3. Apart from the psychological impact of PHN, the requirement has a largest impact on day-to-day comings and goings, such as tough work, sleep lightly and even getting wearing clothes with one in three ancestors not individual competent to contribute in any day-to-day activities prior to treatment3. In enhancement, 92% of patients perpetual to suffer pain even whilst on treatment and over two thirds be displeased with existing treatment options3.

“Versatis offers clinicians an successful and well-tolerated new treatment likelihood for people angst the insupportable shooting, stabbing and burning pain symptoms subsequent shingles,” said Professor Richard Langford, Professor of Anaesthesia & Pain Medicine at St Bartholomew’s Hospital London. “It is generally elder people who come reciprocally post-herpetic neuralgia after shingles and hence with their multiple morbidities and medication, the exceedingly thin systemic horizontal of lidocaine during Versatis avail yourself of, minimises concern a second ago about contraindications and drug interactions.” More than one million patients have been immoderation with the lidocaine plaster since 1999 in the US4. Marketed as Lidoderm(R) by Endo Pharmaceuticals its use demonstrate greatest quality of life5 and higher pain relief6 report to their other treatment.  Grünenthal research, develop and dispense sour big therapeutic good spine tablets and market them for the occupancy of the world. Grünenthal is an control in drugs for pain dream therapy and gynaecology and a ringleader in the canton of bright, user-friendly drug dissemination technology. Grünenthal is an self-sufficient, family-owned people with a drawn out long-ago of multinational co-operations. The company be found in 1946 and has its headquarters in Germany. We give our markets from seven productivity surroundings about the world and have affiliate in 27 country. Grünenthal employ about 1,900 people in Germany and about 4,700 world-wide. Sales in 2005 amounted to round about 777 million Euro.

— Post-herpetic Neuralgia (PHN) is a prolonged neuropathic or guts pain that follow an acute criticism of shingles.

— Shingles or herpes zoster is an acute infection wreak by the reactivation of the secret varicella-zoster virus (chickenpox). After a early stages rooster pox infection the virus lies embryonic in the dorsal nitty-gritty ganglion of the spinal line. An acute shingles hot-headed keep on when the virus is reactivated7.

— PHN affect approximately 200,000 people in the UK8.

The researchers are conduct a prolongation study involving stroke-free nation who soak up be judge by echocardiography. By after that them over event, Di Tullio and his contacts anticipation to further clarify the confederation linking LVD and stroke by defining the annual risk of stroke associated with LVD of not like degree.

References 1. Versatis Summary of Product Characteristics 2. Rowbotham MC et al. Pain 1996; 65: 39-44 3. The Barts Pain Research Group. Post-herpetic Neuralgia: The patient’s voice.

4. Grünenthal information on murmur (Patient exposure) 5. Gammaitoni AR et al. Safety and Tolerability of the Lidocaine Patch 5%, a Targeted Peripheral Analgesic: A Review of the Literature. J Clin Pharmacol 2003;43: 111-117 6. Katz NP et al. Lidocaine Patch 5% Reduces Pain Intensity and Interference with Quality of Life in Patients With Postherpetic Neuralgia. Pain Med 2002; 3(4) 324-332 7. Prodigy Guidance: Shingles and post-herpetic neuralgia 8. Shingles Support Society. Bowsher D. Treatment of post-herpetic neuralgia in the elderlyl

Visit ampills testimonials